News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2018

15 August, 2018 Delivery of study drug to the PledOx® phase III program is expected in September News English Regulatory IR Optional
24 April, 2018 Interim Report January-March 2018 News English Regulatory MAR Report Interim Q1 IR Optional
Previous

Calendar and upcoming reports

December 18, 2024
Investor Day (Stockholm & online)

February 26, 2025
Year-end Report Q4 2024 (7:00am CET)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]